Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-084492
Filing Date
2024-08-01
Accepted
2024-07-31 20:23:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2420558d1_424b5.htm 424B5 573075
2 GRAPHIC tm2420558d1_424b5img01.jpg GRAPHIC 2253
3 GRAPHIC tm2420558d1_424b5img02.jpg GRAPHIC 10090
  Complete submission text file 0001104659-24-084492.txt   591733
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278334 | Film No.: 241163708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)